Trendingnow
Tech

By Norah Rami, Matthew Griffin and BloombergAugust 29, 2026

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine
By Avalon Pernell, Lisa Pham and BloombergAugust 29, 2026


By Sasha RogelbergAugust 28, 2026

By Kaitlyn Huamani and The Associated PressAugust 28, 2026

By Kamal AhmedAugust 27, 2026

By Catherina GioinoAugust 28, 2026
Latest stories from Fortune
More TechPage 50 of 100

By Jason MaMay 30, 2026

By Sebastian HerreraMay 30, 2026

By Marco Quiroz-GutierrezMay 30, 2026

By Mustakim Hasnath and The Associated PressMay 30, 2026

By Emma Burrows and The Associated PressMay 30, 2026

By Matt RogersMay 30, 2026

By Daryl Lim and The ConversationMay 30, 2026

By Anat Lior and The ConversationMay 30, 2026

By Nathan Schneider and The ConversationMay 30, 2026

By Rakesh KumarMay 30, 2026

By Shlomit WagmanMay 30, 2026

By Beatrice NolanMay 29, 2026

By Sebastian HerreraMay 29, 2026

By Beatrice NolanMay 29, 2026

By Philip MartinMay 29, 2026

By Jack KubinecMay 29, 2026

By Emma BurleighMay 29, 2026

By Jaimie Ding and The Associated PressMay 29, 2026

By Catherina GioinoMay 29, 2026

By Wyatte Grantham-Philips and The Associated PressMay 29, 2026

By Sheryl EstradaMay 29, 2026

By Tarika BarrettMay 29, 2026

By Marcia Dunn and The Associated PressMay 29, 2026

By Rob CollieMay 29, 2026

By Christine LentzMay 29, 2026

By Julia Dhar, Kristy R. Ellmer and Philip JamesonMay 29, 2026

By Nick LichtenbergMay 29, 2026
Most Popular




















